Comment on: measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent.

J Antimicrob Chemother

URMITE, UMR63, CNRS 7278, IRD 198, Inserm 1095, Aix Marseille Université, 13005 Marseille, France

Published: June 2014

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dku061DOI Listing

Publication Analysis

Top Keywords

comment measurements
4
measurements vitro
4
vitro anti-mycobacterial
4
anti-mycobacterial activity
4
activity ivermectin
4
ivermectin method-dependent
4
comment
1
vitro
1
anti-mycobacterial
1
activity
1

Similar Publications

Comment on: "Measured glomerular filtration rate based on iohexol: Towards an application in liver transplantation.".

Dig Liver Dis

January 2025

Service d'Hépato-gastroentérologie. CHU Dupuytren. 2, avenue Martin Luther Ling. 87042 Limoges. France; Unité Mixte de Recherche UMR-1248 « Pharmacologie et Transplantation », Faculté de Médecine et de Pharmacie, Université de Limoges. 2, rue du Dr Marcland, 87024 Limoges, France.

View Article and Find Full Text PDF

Microsensor systems for cell metabolism - from 2D culture to organ-on-chip (2019-2024).

Lab Chip

January 2025

Laboratory for Electrical Instrumentation and Embedded Systems, IMTEK - Department of Microsystems Engineering, University of Freiburg, Georges-Köhler-Allee 103, 79110 Freiburg, Germany.

Cell cultures, organs-on-chip and microphysiological systems become increasingly relevant as models, , in drug development, disease modelling, toxicology or cancer research. It has been underlined repeatedly that culture conditions and metabolic cues have a strong or even essential influence on the reproducibility and validity of such experiments but are often not appropriately measured or controlled. Here we review microsensor systems for cell metabolism for the continuous measurement of culture conditions in microfluidic and lab-on-chip platforms.

View Article and Find Full Text PDF

Introduction: Cognitive impairment in Parkinson's disease (PD) substantially affects patient outcomes, function, and quality of life. PD-related cognitive dysfunction is often heterogeneous in clinical presentation and rates of progression. As cognitive changes occur in many people with PD, it is essential to evaluate cognition, provide education, and implement management strategies for cognitive symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!